CHF 205.8
(-0.68%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 135.96 Million CHF | -6.84% |
2022 | 145.95 Million CHF | 3.42% |
2021 | 141.12 Million CHF | 14.74% |
2020 | 122.99 Million CHF | 38.33% |
2019 | 88.91 Million CHF | 1.73% |
2018 | 87.4 Million CHF | 6.91% |
2017 | 81.76 Million CHF | 19.09% |
2016 | 68.65 Million CHF | 2.58% |
2015 | 66.92 Million CHF | 16.11% |
2014 | 57.64 Million CHF | 5.84% |
2013 | 54.46 Million CHF | 4.12% |
2012 | 52.3 Million CHF | 2.02% |
2011 | 51.27 Million CHF | -8.4% |
2010 | 55.97 Million CHF | -6.07% |
2009 | 59.58 Million CHF | 91.04% |
2008 | 31.19 Million CHF | -48.27% |
2007 | 60.29 Million CHF | 18.57% |
2006 | 50.85 Million CHF | 104.84% |
2005 | 24.82 Million CHF | 48.22% |
2004 | 16.74 Million CHF | -24.46% |
2003 | 22.17 Million CHF | -50.4% |
2002 | 44.7 Million CHF | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 25.97 Million CHF | 0.0% |
2023 Q2 | 61.5 Million CHF | 0.0% |
2023 FY | 135.96 Million CHF | -6.84% |
2023 Q4 | 67.59 Million CHF | 0.0% |
2022 FY | 145.95 Million CHF | 3.42% |
2022 Q2 | 79.81 Million CHF | 0.0% |
2022 Q4 | 66.13 Million CHF | 0.0% |
2021 Q2 | 96.25 Million CHF | 0.0% |
2021 Q4 | 44.87 Million CHF | 0.0% |
2021 FY | 141.12 Million CHF | 14.74% |
2020 Q4 | 78.31 Million CHF | 0.0% |
2020 FY | 122.99 Million CHF | 38.33% |
2020 Q2 | 42.62 Million CHF | 0.0% |
2019 Q2 | 32.99 Million CHF | 0.0% |
2019 FY | 88.91 Million CHF | 1.73% |
2019 Q4 | 54.88 Million CHF | 0.0% |
2018 Q2 | 38.01 Million CHF | 0.0% |
2018 Q4 | 49.39 Million CHF | 0.0% |
2018 FY | 87.4 Million CHF | 6.91% |
2017 Q2 | 30.28 Million CHF | 0.0% |
2017 Q4 | 51.47 Million CHF | 0.0% |
2017 FY | 81.76 Million CHF | 19.09% |
2016 Q4 | 40.91 Million CHF | 0.0% |
2016 FY | 68.65 Million CHF | 2.58% |
2016 Q2 | 27.73 Million CHF | 0.0% |
2015 Q2 | 25.26 Million CHF | 0.0% |
2015 FY | 66.92 Million CHF | 16.11% |
2015 Q4 | 41.66 Million CHF | 0.0% |
2014 FY | 57.64 Million CHF | 5.84% |
2014 Q2 | 22.32 Million CHF | 0.0% |
2014 Q4 | 35.32 Million CHF | 0.0% |
2013 Q2 | 23.12 Million CHF | 0.0% |
2013 FY | 54.46 Million CHF | 4.12% |
2013 Q4 | 31.34 Million CHF | 0.0% |
2012 Q1 | 13.14 Million CHF | 0.0% |
2012 Q4 | 14 Million CHF | 6.55% |
2012 Q3 | 13.14 Million CHF | 0.0% |
2012 Q2 | 13.14 Million CHF | 0.0% |
2012 FY | 52.3 Million CHF | 2.02% |
2011 Q3 | 14.08 Million CHF | 0.0% |
2011 FY | 51.27 Million CHF | -8.4% |
2011 Q1 | 14.08 Million CHF | 0.0% |
2011 Q2 | 14.08 Million CHF | 0.0% |
2011 Q4 | 13.14 Million CHF | -6.68% |
2010 Q3 | 13.99 Million CHF | 0.0% |
2010 FY | 55.97 Million CHF | -6.07% |
2010 Q1 | 13.99 Million CHF | 0.0% |
2010 Q2 | 13.99 Million CHF | 0.0% |
2010 Q4 | 14.08 Million CHF | 0.65% |
2009 Q2 | 15.59 Million CHF | 0.0% |
2009 FY | 59.58 Million CHF | 91.04% |
2009 Q1 | 15.59 Million CHF | 0.0% |
2009 Q3 | 15.59 Million CHF | 0.0% |
2009 Q4 | 13.99 Million CHF | -10.3% |
2008 FY | 31.19 Million CHF | -48.27% |
2008 Q1 | 8.49 Million CHF | 0.0% |
2008 Q2 | 8.49 Million CHF | 0.0% |
2008 Q3 | 8.49 Million CHF | 0.0% |
2008 Q4 | 15.59 Million CHF | 83.55% |
2007 Q1 | 16.04 Million CHF | 0.0% |
2007 Q4 | 8.49 Million CHF | -47.04% |
2007 Q3 | 16.04 Million CHF | 0.0% |
2007 Q2 | 16.04 Million CHF | 0.0% |
2007 FY | 60.29 Million CHF | 18.57% |
2006 Q2 | 13.12 Million CHF | 0.0% |
2006 Q3 | 13.12 Million CHF | 0.0% |
2006 FY | 50.85 Million CHF | 104.84% |
2006 Q4 | 16.04 Million CHF | 22.24% |
2006 Q1 | 13.12 Million CHF | 0.0% |
2005 Q4 | 13.12 Million CHF | 137.74% |
2005 FY | 24.82 Million CHF | 48.22% |
2005 Q1 | 5.52 Million CHF | 0.0% |
2005 Q2 | 5.52 Million CHF | 0.0% |
2005 Q3 | 5.52 Million CHF | 0.0% |
2004 FY | 16.74 Million CHF | -24.46% |
2004 Q4 | 5.52 Million CHF | 23.18% |
2004 Q1 | 4.48 Million CHF | 0.0% |
2004 Q2 | 4.48 Million CHF | 0.0% |
2004 Q3 | 4.48 Million CHF | 0.0% |
2003 Q2 | 5.24 Million CHF | 0.0% |
2003 Q4 | 4.48 Million CHF | -14.58% |
2003 Q3 | 5.24 Million CHF | 0.0% |
2003 FY | 22.17 Million CHF | -50.4% |
2003 Q1 | 5.24 Million CHF | 0.0% |
2002 Q4 | 5.24 Million CHF | -52.06% |
2002 Q2 | 10.94 Million CHF | 0.0% |
2002 Q1 | 10.94 Million CHF | 0.0% |
2002 FY | 44.7 Million CHF | 0.0% |
2002 Q3 | 10.94 Million CHF | 0.0% |
2001 Q4 | 10.94 Million CHF | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Relief Therapeutics Holding AG | -110.82 Million CHF | 222.683% |
Santhera Pharmaceuticals Holding AG | 68.84 Million CHF | -97.5% |
Basilea Pharmaceutica AG | 19.2 Million CHF | -607.977% |
Bachem Holding AG | 129.38 Million CHF | -5.091% |
Siegfried Holding AG | 172.06 Million CHF | 20.981% |
Molecular Partners AG | -61.1 Million CHF | 322.503% |